{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:43:29Z","timestamp":1790959409604,"version":"4.1.0"},"reference-count":56,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Margaret R. Larson Professorship"},{"name":"The Carol Swarts, MD Emerging Neuroscience Research Laboratory"},{"name":"The Frances and Louie Blumkin and Harriet Singer Research Foundations"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R01 NS034239"],"award-info":[{"award-number":["2R01 NS034239"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 DA028555"],"award-info":[{"award-number":["P01 DA028555"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 MH64570"],"award-info":[{"award-number":["P01 MH64570"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 NS31492"],"award-info":[{"award-number":["P01 NS31492"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 NS43985"],"award-info":[{"award-number":["P01 NS43985"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG043540"],"award-info":[{"award-number":["R01 AG043540"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS36126"],"award-info":[{"award-number":["R01 NS36126"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_nipt-2024-0018_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Amyloid-\u03b2 (A\u03b2) plaque deposition in the brain is a principal pathological feature of both Alzheimer\u2019s disease (AD) and progressive human immunodeficiency virus type one (HIV-1) infection. Both enable A\u03b2 assembly and A\u03b2 protein aggregation. The potential link between HIV-1 and AD remains uncertain, supporting the need for a reliable animal model. HIV-1 is tropic and pathogenic for humans. It does not replicate in mice. The restricted species tropism has slowed progress in basic research activities. The current study seeks to correct animal model limitations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_nipt-2024-0018_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We created an AD mouse to address the need to develop an small animal model that allows studies of viral infection by making a knock-in (KI) with the human amyloid precursor protein (APP)<jats:sup>KM670,671NL<\/jats:sup> Swedish mutation to the mouse genome. The resulting founder mice were crossed with immunodeficient NOG (NOD. Cg-<jats:italic>Prkdc<\/jats:italic>\n                     <jats:sup>\n                        <jats:italic>scid<\/jats:italic>\n                     <\/jats:sup>\n                     <jats:italic>Il2rg<\/jats:italic>\n                     <jats:sup>\n                        <jats:italic>tm1Sug<\/jats:italic>\n                     <\/jats:sup>Tg(CMV<jats:italic>-IL-34<\/jats:italic>)<jats:italic>1<\/jats:italic>\/Jic) to generate NOG\/APP<jats:sup>KM670,671NL<\/jats:sup>\/IL-34 (NAIL) mice. The mice were reconstituted with human hematopoietic stem cells to generate NAIL mice with functional adaptive and innate human immune systems. Four-month-old, humanized NAIL mice were infected with HIV-1<jats:sub>ADA<\/jats:sub>, a macrophage-tropic viral strain then evaluated for viral infection and AD pathology.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_nipt-2024-0018_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Productive HIV-1 infection was confirmed by plasma HIV-1 RNA levels in infected NAIL mice. The viral load increased by tenfold between day 10 and day 25 post-infection. By day 25, viral DNA confirmed the establishment of HIV-1 reservoirs in CD45+ cells from the immune tissues of infected NAIL mice. Additionally, p24 measurements in lymphoid and brain tissues of NAIL mice validated productive HIV-1 infection. Amyloid burden from infected NAIL mice was increased. Immunofluorescence staining revealed co-localization of A\u03b2 fibrils and HLA-DR<jats:sup>+<\/jats:sup> microglia in infected NAIL mice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_nipt-2024-0018_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These results highlight the AD-HIV model\u2019s unique pathobiological and infectious features where the viral and immune responses can now be measured.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/nipt-2024-0018","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T02:40:41Z","timestamp":1738982441000},"page":"27-38","source":"Crossref","is-referenced-by-count":6,"title":["HIV-1 infection facilitates Alzheimer\u2019s disease pathology in humanized APP knock-in immunodeficient mice"],"prefix":"10.1515","volume":"4","author":[{"given":"Shaurav","family":"Bhattarai","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine , University of Nebraska Medical Science , Omaha , NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Kadry","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine , University of Nebraska Medical Science , Omaha , NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Yeapuri","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine , University of Nebraska Medical Science , Omaha , NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaman","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine , University of Nebraska Medical Science , Omaha , NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma G.","family":"Foster","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine , University of Nebraska Medical Science , Omaha , NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0785-1292","authenticated-orcid":false,"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine , University of Nebraska Medical Science , Omaha , NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanta","family":"Dash","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine , University of Nebraska Medical Science , Omaha , NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa Y.","family":"Poluektova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine , University of Nebraska Medical Science , Omaha , NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhi","family":"Gorantla","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine , University of Nebraska Medical Science , Omaha , NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4241-6149","authenticated-orcid":false,"given":"R. Lee","family":"Mosley","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine , University of Nebraska Medical Science , Omaha , NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-0370","authenticated-orcid":false,"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience, College of Medicine , University of Nebraska Medical Science , Omaha , NE , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"2025043006593982416_j_nipt-2024-0018_ref_001","doi-asserted-by":"crossref","unstructured":"Wei, J, Hou, J, Su, B, Jiang, T, Guo, C, Wang, W, et al.. The prevalence of frascati-criteria-based HIV-associated neurocognitive disorder (HAND) in HIV-infected adults: a systematic review and meta-analysis. Front Neurol 2020;11:581346. https:\/\/doi.org\/10.3389\/fneur.2020.581346.","DOI":"10.3389\/fneur.2020.581346"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_002","doi-asserted-by":"crossref","unstructured":"Heaton, RK, Franklin, DR, Ellis, RJ, McCutchan, JA, Letendre, SL, Leblanc, S, et al.. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011;17:3\u201316. https:\/\/doi.org\/10.1007\/s13365-010-0006-1.","DOI":"10.1007\/s13365-010-0006-1"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_003","unstructured":"Daniel, EM, Mahlab-Guri, K, Bazalel-Rosenberg, S, Attali, M, Asher, I. HIV-associated neurocognitive disorders (HAND). Isr Med Assoc J 2015;17:54."},{"key":"2025043006593982416_j_nipt-2024-0018_ref_004","doi-asserted-by":"crossref","unstructured":"Yu, X, Kuo, YF, Raji, MA, Berenson, AB, Baillargeon, J, Giordano, TP. Dementias among older males and females in the U.S. medicare system with and without HIV. J Acquir Immune Defic Syndr 2023;93:107\u201315. https:\/\/doi.org\/10.1097\/qai.0000000000003184.","DOI":"10.1097\/QAI.0000000000003184"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_005","doi-asserted-by":"crossref","unstructured":"Shayegi-Nik, S, Honer, WG, Vila-Rodriguez, F, Nanditha, NGA, Patterson, TL, Guillemi, S, et al.. Incidence and contributing factors of dementia among people living with HIV in British Columbia, Canada, from 2002 to 2016: a retrospective cohort study. BMJ Public Health 2024;2. https:\/\/doi.org\/10.1136\/bmjph-2023-000627.","DOI":"10.1136\/bmjph-2023-000627"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_006","doi-asserted-by":"crossref","unstructured":"Better, MA. 2023 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dementia 2023;19:1598\u2013695.","DOI":"10.1002\/alz.13016"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_007","doi-asserted-by":"crossref","unstructured":"Liu, Y, Tan, Y, Zhang, Z, Yi, M, Zhu, L, Peng, W. The interaction between ageing and Alzheimer\u2019s disease: insights from the hallmarks of ageing. Transl Neurodegener 2024;13:7. https:\/\/doi.org\/10.1186\/s40035-024-00397-x.","DOI":"10.1186\/s40035-024-00397-x"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_008","doi-asserted-by":"crossref","unstructured":"Trejo-Lopez, JA, Yachnis, AT, Prokop, S. Neuropathology of Alzheimer\u2019s disease. Neurotherapeutics 2022;19:173\u201385. https:\/\/doi.org\/10.1007\/s13311-021-01146-y.","DOI":"10.1007\/s13311-021-01146-y"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_009","doi-asserted-by":"crossref","unstructured":"Canet, G, Dias, C, Gabelle, A, Simonin, Y, Gosselet, F, Marchi, N, et al.. HIV neuroinfection and Alzheimer\u2019s disease: similarities and potential links? Front Cell Neurosci 2018;12:307. https:\/\/doi.org\/10.3389\/fncel.2018.00307.","DOI":"10.3389\/fncel.2018.00307"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_010","doi-asserted-by":"crossref","unstructured":"Mackiewicz, MM, Overk, C, Achim, CL, Masliah, E. Pathogenesis of age-related HIV neurodegeneration. J Neurovirol 2019;25:622\u201333. https:\/\/doi.org\/10.1007\/s13365-019-00728-z.","DOI":"10.1007\/s13365-019-00728-z"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_011","doi-asserted-by":"crossref","unstructured":"Rubin, LH, Sundermann, EE, Moore, DJ. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer\u2019s disease. J Neurovirol 2019;25:661\u201372. https:\/\/doi.org\/10.1007\/s13365-018-0702-9.","DOI":"10.1007\/s13365-018-0702-9"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_012","doi-asserted-by":"crossref","unstructured":"Bernton, EW, Bryant, HU, Decoster, MA, Orenstein, JM, Ribas, JL, Meltzer, MS, et al.. No direct neuronotoxicity by HIV-1 virions or culture fluids from HIV-1-infected T cells or monocytes. AIDS Res Hum Retroviruses 1992;8:495\u2013503. https:\/\/doi.org\/10.1089\/aid.1992.8.495.","DOI":"10.1089\/aid.1992.8.495"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_013","doi-asserted-by":"crossref","unstructured":"Zahoor, MA, Xue, G, Sato, H, Aida, Y. Genome-wide transcriptional profiling reveals that HIV-1 Vpr differentially regulates interferon-stimulated genes in human monocyte-derived dendritic cells. Virus Res 2015;208:156\u201363. https:\/\/doi.org\/10.1016\/j.virusres.2015.06.017.","DOI":"10.1016\/j.virusres.2015.06.017"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_014","doi-asserted-by":"crossref","unstructured":"De Clercq, J, De Scheerder, MA, Mortier, V, Verhofstede, C, Vandecasteele, SJ, Allard, SD, et al.. Longitudinal patterns of inflammatory mediators after acute HIV infection correlate to intact and total reservoir. Front Immunol 2023;14:1337316. https:\/\/doi.org\/10.3389\/fimmu.2023.1337316.","DOI":"10.3389\/fimmu.2023.1337316"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_015","doi-asserted-by":"crossref","unstructured":"Chiarini, A, Armato, U, Hu, P, Dal Pr\u00e0, I. Danger-sensing\/patten recognition receptors and neuroinflammation in Alzheimer\u2019s disease. Int J Mol Sci 2020;21. https:\/\/doi.org\/10.3390\/ijms21239036.","DOI":"10.3390\/ijms21239036"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_016","doi-asserted-by":"crossref","unstructured":"Achim, CL, Adame, A, Dumaop, W, Everall, IP, Masliah, E, Neurobehavioral Research, C. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol 2009;4:190\u20139. https:\/\/doi.org\/10.1007\/s11481-009-9152-8.","DOI":"10.1007\/s11481-009-9152-8"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_017","doi-asserted-by":"crossref","unstructured":"Fulop, T, Witkowski, JM, Larbi, A, Khalil, A, Herbein, G, Frost, EH. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer\u2019s disease? J Neurovirol 2019;25:634\u201347. https:\/\/doi.org\/10.1007\/s13365-019-00732-3.","DOI":"10.1007\/s13365-019-00732-3"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_018","doi-asserted-by":"crossref","unstructured":"Umlauf, A, Soontornniyomkij, B, Sundermann, EE, Gouaux, B, Ellis, RJ, Levine, AJ, et al.. Risk of developing cerebral \u03b2-amyloid plaques with posttranslational modification among HIV-infected adults. AIDS 2019;33:2157\u201366. https:\/\/doi.org\/10.1097\/qad.0000000000002336.","DOI":"10.1097\/QAD.0000000000002336"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_019","doi-asserted-by":"crossref","unstructured":"Ellis, RJ, Marquine, MJ, Kaul, M, Fields, JA, Schlachetzki, JCM. Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management. Nat Rev Neurol 2023;19:668\u201387. https:\/\/doi.org\/10.1038\/s41582-023-00879-y.","DOI":"10.1038\/s41582-023-00879-y"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_020","doi-asserted-by":"crossref","unstructured":"Vijayan, M, Yin, L, Reddy, PH, Benamar, K. Behavioral evidence for a tau and HIV-gp120 interaction. Int J Mol Sci 2022;23. https:\/\/doi.org\/10.3390\/ijms23105514.","DOI":"10.3390\/ijms23105514"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_021","doi-asserted-by":"crossref","unstructured":"Borrajo, A, Spuch, C, Penedo, MA, Olivares, JM, Agis-Balboa, RC. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis. Ann Med 2021;53:43\u201369. https:\/\/doi.org\/10.1080\/07853890.2020.1814962.","DOI":"10.1080\/07853890.2020.1814962"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_022","doi-asserted-by":"crossref","unstructured":"Koenig, S, Gendelman, HE, Orenstein, JM, Dal Canto, MC, Pezeshkpour, GH, Yungbluth, M, et al.. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with rncephalopathy. Science 1986;233:1089\u201393. https:\/\/doi.org\/10.1126\/science.3016903.","DOI":"10.1126\/science.3016903"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_023","doi-asserted-by":"crossref","unstructured":"de Almeida, SM, Ribeiro, CE, Rotta, I, Letendre, S, Potter, M, Tang, B, et al.. Blood amyloid-beta protein isoforms are affected by HIV-1 in a subtype-dependent pattern. J Neurovirol 2020;26:3\u201313. https:\/\/doi.org\/10.1007\/s13365-019-00783-6.","DOI":"10.1007\/s13365-019-00783-6"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_024","doi-asserted-by":"crossref","unstructured":"Waight, E, Zhang, C, Mathews, S, Kevadiya, BD, Lloyd, KCK, Gendelman, HE, et al.. Animal models for studies of HIV-1 brain reservoirs. J Leukoc Biol 2022;112:1285\u201395. https:\/\/doi.org\/10.1002\/jlb.5vmr0322-161r.","DOI":"10.1002\/JLB.5VMR0322-161R"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_025","doi-asserted-by":"crossref","unstructured":"Chemparthy, DT, Kannan, M, Gordon, L, Buch, S, Sil, S. Alzheimer\u2019s-like pathology at the cossroads of HIV-associated neurological disorders. Vaccines 2021;9. https:\/\/doi.org\/10.3390\/vaccines9080930.","DOI":"10.3390\/vaccines9080930"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_026","doi-asserted-by":"crossref","unstructured":"Hategan, A, Masliah, E, Nath, A. HIV and Alzheimer\u2019s disease: complex interactions of HIV-Tat with amyloid \u03b2 peptide and Tau protein. J Neurovirol 2019;25:648\u201360. https:\/\/doi.org\/10.1007\/s13365-019-00736-z.","DOI":"10.1007\/s13365-019-00736-z"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_027","doi-asserted-by":"crossref","unstructured":"Alisky, JM. The coming problem of HIV-associated Alzheimer\u2019s disease. Med Hypotheses 2007;69:1140\u20133. https:\/\/doi.org\/10.1016\/j.mehy.2007.02.030.","DOI":"10.1016\/j.mehy.2007.02.030"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_028","doi-asserted-by":"crossref","unstructured":"Thaney, VE, Sanchez, AB, Fields, JA, Minassian, A, Young, JW, Maung, R, et al.. Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. J Neurovirol 2018;24:156\u201367. https:\/\/doi.org\/10.1007\/s13365-017-0584-2.","DOI":"10.1007\/s13365-017-0584-2"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_029","doi-asserted-by":"crossref","unstructured":"Su, H, Cheng, Y, Sravanam, S, Mathews, S, Gorantla, S, Poluektova, LY, et al.. Immune activations and viral tissue compartmentalization during progressive HIV-1 infection of humanized mice. Front Immunol 2019;10:340. https:\/\/doi.org\/10.3389\/fimmu.2019.00340.","DOI":"10.3389\/fimmu.2019.00340"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_030","doi-asserted-by":"crossref","unstructured":"Bhargavan, B, Woollard, SM, McMillan, JE, Kanmogne, GD. CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice. Mol Neurodegener 2021;16:78. https:\/\/doi.org\/10.1186\/s13024-021-00500-0.","DOI":"10.1186\/s13024-021-00500-0"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_031","doi-asserted-by":"crossref","unstructured":"Bhattarai, S, Yeapuri, P, Machhi, J, Lu, Y, Kadry, R, Foster, EG, et al.. HIV-1 infection and Alzheimer\u2019s disease pathobiology in a novel humanized APP-knock in mouse model. Top Antivir Med 2024;32:575.","DOI":"10.1515\/nipt-2024-0018"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_032","doi-asserted-by":"crossref","unstructured":"Mathews, S, Branch Woods, A, Katano, I, Makarov, E, Thomas, MB, Gendelman, HE, et al.. Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice. Mol Neurodegener 2019;14:12. https:\/\/doi.org\/10.1186\/s13024-019-0311-y.","DOI":"10.1186\/s13024-019-0311-y"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_033","doi-asserted-by":"crossref","unstructured":"Boucher, T, Liang, S, Brown, AM. Advancing basic and translational research to deepen understanding of the molecular immune-mediated mechanisms regulating long-term persistence of HIV-1 in microglia in the adult human brain. J Leukoc Biol 2022;112:1223\u201331. https:\/\/doi.org\/10.1002\/jlb.1mr0422-620r.","DOI":"10.1002\/JLB.1MR0422-620R"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_034","doi-asserted-by":"crossref","unstructured":"Ndondo, AP, Eley, B, Wilmshurst, JM, Kakooza-Mwesige, A, Giannoccaro, MP, Willison, HJ, et al.. Post-infectious autoimmunity in the central (CNS) and peripheral (PNS) nervous systems: an African perspective. Front Immunol 2022;13:833548. https:\/\/doi.org\/10.3389\/fimmu.2022.833548.","DOI":"10.3389\/fimmu.2022.833548"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_035","doi-asserted-by":"crossref","unstructured":"Ulland, TK, Colonna, M. TREM2 \u2013 a key player in microglial biology and Alzheimer disease. Nat Rev Neurol 2018;14:667\u201375. https:\/\/doi.org\/10.1038\/s41582-018-0072-1.","DOI":"10.1038\/s41582-018-0072-1"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_036","doi-asserted-by":"crossref","unstructured":"Sayed, FA, Kodama, L, Fan, L, Carling, GK, Udeochu, JC, Le, D, et al.. AD-linked R47H-TREM2 mutation induces disease-enhancing microglial states via AKT hyperactivation. Sci Transl Med 2021;13:eabe3947. https:\/\/doi.org\/10.1126\/scitranslmed.abe3947.","DOI":"10.1126\/scitranslmed.abe3947"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_037","doi-asserted-by":"crossref","unstructured":"Gupta, RK, Abdul-Jawad, S, McCoy, LE, Mok, HP, Peppa, D, Salgado, M, et al.. HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation. Nature 2019;568:244\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1027-4.","DOI":"10.1038\/s41586-019-1027-4"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_038","doi-asserted-by":"crossref","unstructured":"Gorantla, S, Makarov, E, Finke-Dwyer, J, Castanedo, A, Holguin, A, Gebhart, CL, et al.. Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. Am J Pathol 2010;177:2938\u201349. https:\/\/doi.org\/10.2353\/ajpath.2010.100536.","DOI":"10.2353\/ajpath.2010.100536"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_039","doi-asserted-by":"crossref","unstructured":"Dash, PK, Chen, C, Kaminski, R, Su, H, Mancuso, P, Sillman, B, et al.. CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice. Proc Natl Acad Sci U S A 2023;120:e2217887120. https:\/\/doi.org\/10.1073\/pnas.2217887120.","DOI":"10.1073\/pnas.2217887120"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_040","doi-asserted-by":"crossref","unstructured":"Zhang, C, Su, H, Waight, E, Poluektova, LY, Gorantla, S, Gendelman, HE, et al.. Accelerated neuroimmune dysfunction in aged HIV-1-Infected humanized mice. Pharmaceuticals 2024;17. https:\/\/doi.org\/10.3390\/ph17020149.","DOI":"10.3390\/ph17020149"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_041","doi-asserted-by":"crossref","unstructured":"Yeapuri, P, Machhi, J, Lu, Y, Abdelmoaty, MM, Kadry, R, Patel, M, et al.. Amyloid-beta specific regulatory T cells attenuate Alzheimer\u2019s disease pathobiology in APP\/PS1 mice. Mol Neurodegener 2023;18:97. https:\/\/doi.org\/10.1186\/s13024-023-00692-7.","DOI":"10.1186\/s13024-023-00692-7"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_042","doi-asserted-by":"crossref","unstructured":"Zhang, J, Lohani, SC, Cheng, Y, Wang, T, Guo, L, Kim, WK, et al.. Human microglia extensively reconstitute in humanized-BLT mice with human interleukin-34 transgene and support HIV-1 brain infection. Front Immunol 2021;12:672415. https:\/\/doi.org\/10.3389\/fimmu.2021.672415.","DOI":"10.3389\/fimmu.2021.672415"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_043","doi-asserted-by":"crossref","unstructured":"Gorantla, S, Poluektova, L, Gendelman, HE. Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci 2012;35:197\u2013208. https:\/\/doi.org\/10.1016\/j.tins.2011.12.006.","DOI":"10.1016\/j.tins.2011.12.006"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_044","doi-asserted-by":"crossref","unstructured":"Thomas, FP, Chalk, C, Lalonde, R, Robitaille, Y, Jolicoeur, P. Expression of human immunodeficiency virus type 1 in the nervous system of transgenic mice leads to neurological disease. J Virol 1994;68:7099\u2013107. https:\/\/doi.org\/10.1128\/jvi.68.11.7099-7107.1994.","DOI":"10.1128\/jvi.68.11.7099-7107.1994"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_045","doi-asserted-by":"crossref","unstructured":"Kim, BO, Liu, Y, Ruan, Y, Xu, ZC, Schantz, L, He, JJ. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol 2003;162:1693\u2013707. https:\/\/doi.org\/10.1016\/s0002-9440(10)64304-0.","DOI":"10.1016\/S0002-9440(10)64304-0"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_046","doi-asserted-by":"crossref","unstructured":"Toggas, SM, Masliah, E, Rockenstein, EM, Rail, GF, Abraham, CR, Mucke, L. Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice. Nature 1994;367:188\u201393. https:\/\/doi.org\/10.1038\/367188a0.","DOI":"10.1038\/367188a0"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_047","doi-asserted-by":"crossref","unstructured":"Tyor, WR, Power, C, Gendelman, HE, Markham, RB. A model of human immunodeficiency virus encephalitis in scid mice. Proc Natl Acad Sci U S A 1993;90:8658\u201362. https:\/\/doi.org\/10.1073\/pnas.90.18.8658.","DOI":"10.1073\/pnas.90.18.8658"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_048","doi-asserted-by":"crossref","unstructured":"Persidsky, Y, Nottet, HSLM, Sasseville, VG, Epstein, LG, Gendelman, HE. The development of animal model systems for HIV-1 encephalitis and its associated dementia. J Neurovirol 1995;1:229\u201343. https:\/\/doi.org\/10.3109\/13550289509114019.","DOI":"10.3109\/13550289509114019"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_049","doi-asserted-by":"crossref","unstructured":"Ito, R, Katano, I, Kawai, K, Yagoto, M, Takahashi, T, Ka, Y, et al.. A novel xenogeneic graft-versus-host disease model for investigating the pathological role of human CD4(+) or CD8(+) T cells using immunodeficient NOG mice. Am J Transplant 2017;17:1216\u201328. https:\/\/doi.org\/10.1111\/ajt.14116.","DOI":"10.1111\/ajt.14116"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_050","doi-asserted-by":"crossref","unstructured":"King, MA, Covassin, L, Brehm, MA, Racki, W, Pearson, T, Leif, J, et al.. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009;157:104\u201318. https:\/\/doi.org\/10.1111\/j.1365-2249.2009.03933.x.","DOI":"10.1111\/j.1365-2249.2009.03933.x"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_051","doi-asserted-by":"crossref","unstructured":"Poluektova, L, Gorantla, S, Faraci, J, Birusingh, K, Dou, H, Gendelman, HE. Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis. J Immunol 2004;172:7610\u20137. https:\/\/doi.org\/10.4049\/jimmunol.172.12.7610.","DOI":"10.4049\/jimmunol.172.12.7610"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_052","doi-asserted-by":"crossref","unstructured":"Watanabe, S, Terashima, K, Ohta, S, Horibata, S, Yajima, M, Shiozawa, Y, et al.. Hematopoietic stem cell-engrafted NOD\/SCID\/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2007;109:212\u20138. https:\/\/doi.org\/10.1182\/blood-2006-04-017681.","DOI":"10.1182\/blood-2006-04-017681"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_053","doi-asserted-by":"crossref","unstructured":"Li, W, Gorantla, S, Gendelman, HE, Poluektova, LY. Systemic HIV-1 infection produces a unique glial footprint in humanized mouse brains. Dis Models Mech 2017;10:1489\u2013502. https:\/\/doi.org\/10.1242\/dmm.031773.","DOI":"10.1101\/178285"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_054","doi-asserted-by":"crossref","unstructured":"Dash, PK, Kaminski, R, Bella, R, Su, H, Mathews, S, Ahooyi, TM, et al.. Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat Commun 2019;10:2753. https:\/\/doi.org\/10.1038\/s41467-019-10366-y.","DOI":"10.1038\/s41467-019-10366-y"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_055","doi-asserted-by":"crossref","unstructured":"Wang, Z, Liu, J, Han, J, Zhang, T, Li, S, Hou, Y, et al.. Herpes simplex virus 1 accelerates the progression of Alzheimer\u2019s disease by modulating microglial phagocytosis and activating NLRP3 pathway. J Neuroinflammation 2024;21:176. https:\/\/doi.org\/10.1186\/s12974-024-03166-9.","DOI":"10.1186\/s12974-024-03166-9"},{"key":"2025043006593982416_j_nipt-2024-0018_ref_056","doi-asserted-by":"crossref","unstructured":"Torniainen-Holm, M, Suvisaari, J, Lindgren, M, Harkanen, T, Dickerson, F, Yolken, RH. Association of cytomegalovirus and Epstein-Barr virus with cognitive functioning and risk of dementia in the general population: 11-year follow-up study. Brain Behav Immun 2018;69:480\u20135. https:\/\/doi.org\/10.1016\/j.bbi.2018.01.006.","DOI":"10.1016\/j.bbi.2018.01.006"}],"container-title":["NeuroImmune Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2024-0018\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2024-0018\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T07:02:45Z","timestamp":1745996565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2024-0018\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,4,10]]},"published-print":{"date-parts":[[2025,3,26]]}},"alternative-id":["10.1515\/nipt-2024-0018"],"URL":"https:\/\/doi.org\/10.1515\/nipt-2024-0018","relation":{},"ISSN":["2750-6665"],"issn-type":[{"value":"2750-6665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]}}}